|
Why Animal Experiments Often Fail in Birth Defects Research
INHERENT PROBLEMS
I. There are inherent problems with animal experiments
in defining and solving the problem of birth defects:
A. "Karnofsky's law" holds that any substance can be teratogenic if given in the right dose to the right species
at the right time. It follows that because all agents have the
potential for toxicity in some organism at some dose, the production
of positive results in developmental toxicity studies is only
a matter of finding a sensitive state in a sensitive species and
of using an adequately high dose of the toxicant.1
B. There are many sources of error in using
animal tests to predict teratogenicity:
1. Species differences:
It is almost invariable to see rats and rabbits used as
test animals, although mice may be used in place of rats. The
choice of rats and rabbits as the primary testing species is
not because they are considered to be particularly similar to humans,
but because they are easy to handle and because their use has
generated an enormous, although not necessarily correct, database.1
Species differences in animal tests for causes of birth defects
are present for many reasons:
a. Differences in genotype from one species
to another and even one strain to another can affect susceptibility
to teratogens.1
b. Different species develop at different
rates and along different schedules. These differences can
affect the interpretation of animal data because chemicals
appear to exert their effect on the fetus at different stages
of development.1
c. Humans may be more sensitive than other
animals because of the longer period of human development.1
d. Species-specific differences in the placenta
may affect the results of animal tests.2
2. The route of administration to the animal
may not be the likely human route. It is not unusual to see
drugs given to animals in teratogenicity tests intraperitoneally,
intravenously, or via gastric tubes.1 Studies in which solvents
whose usual source of human exposure is through inhalation or
dermal absorption, may be given to animals intravenously or
via gastric tubes.3
3. The dosing schedule in animals may not
mimic the schedule in humans. Although animals are usually given
the chemical once a day, daily dosing is unusual for human exposure,
either therapeutic or environmental, and results from this bolus
dosing may be misleading.1 For example, some agents are teratogenic
only if the peak concentration reached in fetal tissues exceeds
a threshold level, even briefly. For others, prolonged exposure
at lower doses may be more predictive of toxic sequelae.
4. One of the doses usually used in animal
tests is that which produces some toxicity in the mother, however,
this may not be applicable to the human situation where the
same maternal effect may not be observed.1
5. Routine animal handling itself may cause
developmental effects. Stress imposed by food or water deprivation
or by restraint has adverse effects on pregnancy outcome.1
6. Animal studies may not be sufficiently
sensitive to detect subtle developmental toxicity such as learning
or behavioral problems, occurring at low dose exposures.1
C. Studies have been done to predict the reliability
of animal data:
In a now classic review on the use of animal teratogenicity testing,
Brown and Fabro summarized information collected by the FDA and
the Council on Environmental Quality. In identifying human teratogens,
mice tests were correct in 85%, rat tests in 80%, rabbit tests
in 60%, hamster tests in 45%, and monkey tests in 30%. When the
same criteria were applied to predict nonteratogens, mice and
hamster tests were correct in 35%, rat tests in 50%, rabbit tests
in 70%, and monkey tests in 80%. (Note that predicting these results
by simply flipping a coin would prove correct 50% of the time.)1
D. An additional problem with animal tests is
their impracticality. Animal teratogenicity tests require a large
investment of time, animals, and money (about $60,000 to test
one chemical in rats and rabbits). Considering the tens of thousands
of chemicals in widespread use (many of them untested) and the
addition of about 1,000 new chemicals per year, testing all of
them is simply not practical.1
E. Animals are also used in the research areas
of fetal and newborn diseases again with the problem of nontransferability
of the data to humans. Nelson's Textbook of Pediatrics states,
"Much of our knowledge of fetal physiology has been obtained
from animals and often is not directly applicable to man."5
II. In contrast to animal experiments, epidemiologic studies
have provided consistently crucial information:
A. Virtually all known developmental hazards
were identified and/or characterized through studies of human
populations.1
B. Epidemiologic studies were responsible for
identifying, among other things the thalidomide disaster, fetal
alcohol syndrome, fetal hydantoin syndrome, fetal rubella syndrome,
the association of folic acid with neural tube defects, and the
effects of DES and methyl mercury on development.4,6
C. One of the most popular reference sources
among genetic counselors is Drugs in Pregnancy and Lactation,
A Reference Guide to Fetal and Neonatal Risk by Briggs, Freeman,
and Yaffe. This important book presents no animal data, but rather
relies solely on human data.1
III. Scientists are turning to in vitro tests to improve
both predictability and practicality because of inherent problems
and inaccuracies in animal testing.
A. In vitro studies offer many advantages. They
are less expensive, faster, and more reproducible than animal
tests.
B. Some in vitro screens have achieved successful
application in labs where they are used to assess the relative
"toxicity" of chemicals within a family defined on thebasis
of structure, functionality, or pharmacologic activity.7
C. “In the long run understanding of the
mechanisms of toxic action and consequently the recognition of
essential endpoints and criteria as indicators of specific toxicologic
potential, largely based on in vitro assays, may hopefully lead
to the development of completely different data sets and hazard
identification schemes that would be far superior to the current
animal tests. Nevertheless, none of the above will lead to a better
world for the experimental animal, when scientists in toxicology
are not really convinced of the necessity to reduce the use of
animals in their research....What is needed most of all is respect
for the life of animals and consequently a positive attitude towards
developments that could lead to a reduction of animal use.”7
D. It is not clear that any of the in vitro
tests in existence today are sufficiently developed at this time
to identify human toxicity with ease or certainty.1 A significant
greater amount of resources need to be devoted to this area.
IV. Conclusion
Reliance on the faulty information obtained from animal tests puts
human health in jeopardy in addition to causing the death and suffering
of many animals. In addition, the progress of science is slowed
as money that could be better spent on clinical studies as well
as the development of more reliable in vitro tests is being wasted
on animal tests.
References
1. Scialli AR. A Clinical Guide to Reproductive and Developmental
Toxicology. CRC Press, Ann Arbor, Mich: 1992.
2. Eighth Special Report to the Congress on Alcohol and Health from
the Secretary of the Department of Health and Human Services.
3. Needlman HN, Bellinger D, eds. Prenatal Exposure to Toxicants.
The Johns Hopkins University Press, Baltimore, Md: 1994.
4. Association of Birth Defect Children.
5. Vaughn VC, McKay RJ, Nelson WE. Nelson Textbook of Pediatrics.
WB Saunders, Philadelphia, Pa: 1975.
6. Hibbard ED, Smithells RW. Folic acid metabolism and human embryopathy.
Lancet 1965;1:1254.
7. Proceedings of the International Workshop on In Vitro Methods
in Reproductive Toxicology. Pergamon Press, New York, NY: 1993.
Media
Center | Health | Research
| About PCRM | Catalog
| Join Us | Search
| Site Index | Home
The site does
not provide medical or legal advice. This Web site is for information purposes
only.
Full Disclaimer | Privacy Policy
|